Your browser doesn't support javascript.
loading
Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine.
Murray, K L; Miller, K M; Pearson, D L.
Affiliation
  • Murray KL; Department of Pharmacy, Centennial Medical Center, Nashville, TN 37203, USA. kara.bazzie@hcahealthcare.com
J Perinatol ; 27(8): 517-8, 2007 Aug.
Article in En | MEDLINE | ID: mdl-17653218
ABSTRACT
We describe a full-term infant with failed respiratory effort and decerebrate posturing following in utero exposure to paroxetine. All signs and symptoms associated with the paroxetine exposure were resolved by the second day of life. Upon discharge, the infant revealed a normal neurodevelopmental examination.
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Insufficiency / Neonatal Abstinence Syndrome / Paroxetine / Antidepressive Agents, Second-Generation / Serotonin Syndrome Type of study: Etiology_studies Limits: Humans / Male / Newborn Language: En Journal: J Perinatol Journal subject: PERINATOLOGIA Year: 2007 Document type: Article Affiliation country: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Insufficiency / Neonatal Abstinence Syndrome / Paroxetine / Antidepressive Agents, Second-Generation / Serotonin Syndrome Type of study: Etiology_studies Limits: Humans / Male / Newborn Language: En Journal: J Perinatol Journal subject: PERINATOLOGIA Year: 2007 Document type: Article Affiliation country: United States